Real-world evidence of switching P2Y12 receptor-inhibiting therapies to prasugrel after PCI in patients with ACS: results from EFF-K registry.
Jeehoon KangJung-Kyu HanHan-Mo YangKyung Woo ParkHyun-Jae KangBon-Kwon KooEun Ho ChooJong-Young LeeSang-Don ParkYoung-Hyo LimHyung-Min KimJi-Hyun HeoHyo-Soo KimPublished in: BMC cardiovascular disorders (2023)
KCT0002356, registered June 13, 2017.
Keyphrases
- acute coronary syndrome
- percutaneous coronary intervention
- antiplatelet therapy
- st segment elevation myocardial infarction
- acute myocardial infarction
- st elevation myocardial infarction
- coronary artery disease
- signaling pathway
- coronary artery bypass grafting
- atrial fibrillation
- coronary artery bypass
- binding protein
- heart failure
- left ventricular